Long-term outcome of rifaximin therapy in non-constipation irritable bowel syndrome

Dig Dis Sci. 2011 Nov;56(11):3389-90. doi: 10.1007/s10620-011-1889-2.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Female
  • Gastrointestinal Agents / therapeutic use*
  • Humans
  • Irritable Bowel Syndrome / drug therapy*
  • Male
  • Rifamycins / therapeutic use*

Substances

  • Gastrointestinal Agents
  • Rifamycins